Oxycodone – first choice medicine for severe cancer pain

Tomasz Dzierżanowski; Aleksandra Ciałkowska-Rysz

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2010
vol. 2

Send email

Copy url:

abstract:

Review paper

Oxycodone – first choice medicine for severe cancer pain

Tomasz Dzierżanowski

,

Aleksandra Ciałkowska-Rysz

Medycyna Paliatywna 2010; 3: 123-131

Online publish date: 2010/10/18

View full text Get citation

Oxycodone is a strong opioid drug prescribed for the treatment of moderate to severe pain. Mode of action on opioid receptors, highly predictable bioavailability after oral administration and availability of controlled release formulations allow for comfortable use in any types of persistent pain (cancer, neuropathic, somatic and visceral). Good quality clinical trials delivered evidence of its effectiveness and safety, as a first-choice medicine for cancer pain treatment, equally to morphine.The following text is aimed to depict general characteristics of oxycodone, as well as the newest and most interesting findings.

keywords:

Oxycodone – first choice medicine for severe cancer pain

Tomasz Dzierżanowski , Aleksandra Ciałkowska-Rysz

oxycodone, cancer pain

Tomasz Dzierżanowski

,

Aleksandra Ciałkowska-Rysz